Rocket Lab $RKLB Sells Out Neutron Through 2030 at $70M+ Per Launch
Two names nobody is talking about are quietly having the best week in the chip and space sectors

Ticker Ratings
Everyone spent this week watching $NVDA implode and $AMD crater 10% in a single session. Totally fair. But while the chip bloodbath dominated every feed, two tickers were quietly going absolutely feral in the opposite direction, and the YouTube crowd is starting to catch on.
First up: $RKLB. Rocket Lab CEO Peter Beck appeared on CNBC this week and dropped a stat that should have stopped every space investor mid-scroll. The Neutron rocket, which has not flown a single mission yet, is sold out through 2030. The list price started at $55 million per launch and is already selling above $70 million because demand is outrunning capacity. The company also just reported a record backlog, up more than 50% sequentially, with nearly $1 billion in launch contracts booked in a single quarter. The Electron rocket hit 100 launches at a 96% reliability rate, faster than any commercially developed rocket in history. The bull case basically writes itself: execution track record, pricing power before first flight, and a medium-lift market with serious pent-up demand. The bear case is simpler too: a lot of this is priced on promises, and construction delays are real across the industry. But when customers are paying a 27% price premium before the rocket exists, that is a trust signal that is hard to argue with.
Then there is $CBRS. Cerebras was the only notable chip name in the green on Friday, up 8% intraday and 12% in premarket after beating Q3 estimates on both top and bottom lines. The company raised full-year guidance and announced a new cloud deal with Microsoft, adding AWS and Oracle as hyperscaler partners in the last six months alone. Bloomberg analysts flagged it as a potential beneficiary of the Nvidia compliance chaos, since Cerebras focuses on fast inference at premium pricing, and that premium is reportedly expanding. The company did acknowledge data center construction delays are affecting deployment timelines, so revenue from these new hyperscaler deals shows up in future quarters, not this one. That is worth watching.
The broader context matters here. The VIX jumped nearly 7% to 18.7 on November 12, the 10-year yield is knocking on 5%, and the Fed is openly discussing a 50 basis point hike in December. That is a genuinely hostile environment for high-multiple growth names. And yet Rocket Lab and Cerebras are holding up, which in this tape is basically the equivalent of showing up to a tornado in a tuxedo and walking out unscathed.
The X crowd has been fixated on the NVDA drama all week, understandably. But the smarter YouTube finance channels are rotating their coverage toward who actually benefits from Nvidia's regulatory and succession mess. Cerebras is the obvious answer on the chip inference side. Rocket Lab has no China exposure, no Jensen problem, and apparently no empty launch slots either.
Sometimes the best trade of the week is the one that is not on anyone's disaster radar.
BullApe's AI grades every pick against the S&P 500 - wins and misses published. See the track record →